Generics Maker Wins Alimta Fight With Lilly In UK Court
Generic drugmaker Actavis PLC would not infringe on the British and European patents of Eli Lilly and Co. if it decided to market a generic version of Lilly's cancer drug Alimta,...To view the full article, register now.
Already a subscriber? Click here to view full article